(Q46133587)

19 December 2017

title

Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort (English)

1 reference

19 December 2017

0 references

1 reference

Jaekyu Shin

1

1 reference

19 December 2017

Diana Cao

series ordinal

2

1 reference

19 December 2017

publication date

1 January 2011

1 reference

19 December 2017

published in

Pharmacogenomics

1 reference

19 December 2017

volume

12

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

125-134

1 reference

19 December 2017

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Role of warfarin pharmacogenetic testing in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Estimation of the warfarin dose with clinical and pharmacogenetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

The largest prospective warfarin-treated cohort supports genetic forecasting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Validation of clinical testing for warfarin sensitivity: comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Genetic and clinical predictors of warfarin dose requirements in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.168

21 January 2018

Identifiers

DOI

10.2217/PGS.10.168

1 reference

19 December 2017

1 reference

19 December 2017